Biodesix (BDSX) Stock: Buy, Sell, or Hold?
$10.02
-0.32 (-3.09%)
▼
5d:
-52.4%
30d:
-61.01%
90d:
-58.63%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$20.29 – $28.13
Position: OVERSOLD
Forward P/E & Valuation
-5.8x
Next 12M consensus est.
Wall Street Target
$33.83
+237.7% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$7.70 / $25.06
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BDSX is down 52.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BDSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BDSX is currently trading at $10.02, which is considered oversold relative to its 30-day fair value range of $20.29 to $28.13.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $7.70, while resistance sits at $25.06. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: BDSX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.83 (+237.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDSX is in a strong uptrend. Immediate support is located at $7.70, while resistance sits at $25.06. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: BDSX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $33.83 (+237.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$20.29 -
$28.13
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$20.29 -
$28.13
Current vs Trading Range
OVERSOLD
Support Level
$7.70
Resistance Level
$25.06
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 237.7% below Wall St target ($33.83)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.76
Wall Street Target
$33.83
(+237.7%)
Revenue Growth (YoY)
10.4%
Profit Margin
-25.7%
Share BDSX Analysis
Share this live BDSX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BDSX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Biodesix to present new data on tumor-informed and tumor-naïve molecular monitoring programs at AMP 2026 Annual Meeting, showcasing collaborations with Bio-Rad Laboratories and Thermo Fisher Scientific.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 6:46 AM ET
Data refreshes hourly during market hours. Next update: 7:46 AM
Data refreshes hourly during market hours. Next update: 7:46 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDSX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 52 HOLD |
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
27 analysts |
$752 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 58 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
24 analysts |
$260 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BDSX Research Pages
